Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03451825
Title Phase I/II Study of Avelumab in Pediatric Cancer Subjects
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

Advanced Solid Tumor

lymphoma

Therapies

Avelumab

Age Groups: adult | child
Covered Countries USA | CAN | BEL


No variant requirements are available.